(688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688062 · · 3 pages · Chinese
Summary by 6ix AI
The briefing is scheduled for November ninth and will be conducted online. The company aims to address common investor questions during this session. Key executives will participate, including the chairman and general manager.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Mabwell (Shanghai) Bioscience Co., Ltd. on 6ix
Story so far
- (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Resolutions of the 4th Meeting of the 3rd Board of Directors
- (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Extension of Certain Raised Funds Investment Project
- (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Voluntary Disclosure of the Oral Presentation of Clinical Data for 9MW2821 at the 2026 European Society for Medical Oncology (ESMO) Congress
Earlier from Mabwell (Shanghai) Bioscience
- (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Report for Q3 2026
- (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Resolutions of the 4th Meeting of the 3rd Board of Directors
- (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Extension of Certain Raised Funds Investment Project
- (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Voluntary Disclosure of the Oral Presentation of Clinical Data for 9MW2821 at the 2026 European Society for Medical Oncology (ESMO) Congress
- (688062)"MABWELL (SHANGHAI) BIOSCIENCE CO., LTD."Announcement on Listing and Trading of Certain Restricted Shares from the Initial Public Offering
Follow Mabwell (Shanghai) Bioscience into a list and get an email when it puts out news.
Follow Mabwell (Shanghai) Bioscience